LUKAS SCHEIBLER Insider Trading $APLS Apellis Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LUKAS SCHEIBLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LUKAS SCHEIBLER. LUKAS SCHEIBLER is EVP of Research & Development in ACUCELA INC. ($M??????) and EVP of Translational Medicine in ACUCELA INC. ($M??????) and CHIEF INNOVATION OFFICER in Apellis Pharmaceuticals, Inc. ($APLS) and See Remarks in Apellis Pharmaceuticals, Inc. ($APLS).
LUKAS SCHEIBLER in Apellis Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LUKAS SCHEIBLER: CHIEF INNOVATION OFFICER, See Remarks
Holdings: 29,290 shares
Latest Transaction: Feb 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LUKAS SCHEIBLER in Apellis Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Payment of Exercise | F | 47.72 | 680 | 32,450 | 29,290 | 30 K to 29.3 K (-2.27 %) |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 11,250 | 505,125 | 11,250 | |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 45,000 | 2,020,500 | 45,000 | |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 1,875 | 0 | 29,970 | 28.1 K to 30 K (+6.67 %) |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 7,500 | 0 | 28,095 | 20.6 K to 28.1 K (+36.42 %) |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 11,250 | 505,125 | 11,250 | |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | A | 44.90 | 45,000 | 2,020,500 | 45,000 | |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 1,875 | 0 | 29,970 | 28.1 K to 30 K (+6.67 %) |
| Feb 01 2021 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Grant | A | 0.00 | 7,500 | 0 | 28,095 | 20.6 K to 28.1 K (+36.42 %) |
| Dec 09 2020 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Option Exercise | M | 26.73 | 7,482 | 199,994 | 137,518 | |
| Dec 09 2020 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | CHIEF INNOVATION OF ... | Buy | M | 26.73 | 7,482 | 199,994 | 20,595 | 13.1 K to 20.6 K (+57.06 %) |
| Feb 12 2020 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | A | 44.33 | 56,250 | 2,493,563 | 56,250 | |
| Feb 12 2020 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Grant | A | 0.00 | 9,375 | 0 | 12,310 | 2.9 K to 12.3 K (+319.42 %) |
| Feb 12 2019 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | A | 13.85 | 85,000 | 1,177,250 | 85,000 | |
| May 29 2018 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Buy | P | 20.37 | 2,935 | 59,786 | 2,935 | 0 to 2.9 K |
| Apr 17 2018 | APLS | Apellis Pharmaceut ... | SCHEIBLER LUKAS | See Remarks | Option Exercise | A | 26.73 | 145,000 | 3,875,850 | 145,000 |
Page: 1